AzTrials
AzTrials

Facial SkinREGARDNCT07080320

Research on the Evolution, Geometry, and Alterations of the Periorbital Region Based on Age and Deformations

A study testing MoCap in people with Facial Skin and Motion Capture, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The periorbital region of the face is a critical area affected by aging. Motion Capture (MoCap) allows the precise measurement of the mechanical properties of skin in this region. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Facial Skin, Motion Capture, Aging
What is being tested?
MoCap
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
20 Sep 2025to Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Female participants
  • Caucasian, Fitzpatrick skin types I-III
  • BMI between 18.5 and 27, healthy participants
  • Aged 18 to 65 years (inclusive)
  • Not under guardianship or curatorship
  • Informed written consent
Show all 9Show fewer
  • Social security affiliation
  • Non-smokers for at least 5 years
  • No excessive UV exposure (artificial or natural) in the last 3 weeks prior to the study or during the study

Who cannot join

  • Severe skin disorders preventing the application of electrodes or photo-reflective markers
  • Neurovascular history affecting the face
  • Ongoing treatments influencing facial tissues (e.g., corticosteroids)
  • Current sleep disorders
  • Psychiatric conditions or social interaction impairments
  • Inner ear or balance disorders
Show all 9Show fewer
  • Osteoporosis, recent fractures, or fragile bone conditions
  • Pregnant or breastfeeding women
  • Under guardianship, curatorship, or legal protection

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHRU Amiens

    Amiens, 80480

Other trials in France

About this study

The periorbital region of the face is a critical area affected by aging. Motion Capture (MoCap) allows the precise measurement of the mechanical properties of skin in this region. This study will validate MoCap as a tool for quantifying these properties, comparing it to traditional reference tools, and exploring how these properties evolve with age and external treatments. It will also assess MoCap's ability to detect the effects of various treatments such as tightening products and massages. Ultimately, this research will provide a deeper understanding of skin dynamics in the periorbital region and offer insights into both medical and cosmetic applications.

Being tested
MoCap
Keywords
Facial skin, motion capture, aging, periorbital region, mechanical, skin movement, vertical jump

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MoCapDevice

    For each subject, the displacement of markers, the deformation of regions between markers, and the evolution of angles formed by the markers during facial expressions and vertical movements will be analyzed with MoCap. These will be compared between the two age groups (18-33 years vs. 50-65 years) using a MANOVA model. The reference values for marker displacement will be defined by the interval between the 2.5% and 97.5% percentiles of the values for each marker. If the distribution is Gaussian, the percentiles will be derived from the standard normal distribution; otherwise, the non-parametric method will be used.

    The intervention will be Interventions :

    • Recruitment of healthy and pathological subjects.
    • Full-face and macro images of the periorbital region
    • Measurement of periorbital skin properties using MoCap and standard reference tools.
    • Application of a tightening product (aloe vera) and periorbital massage.
    • Measurement of skin response to a vertical jump.
Study groups in NCT07080320
Study groupRoleWhat they receive
subjects aged 18-33 yearsExperimentalNot described
Receives: Device: MoCap
subjects aged 50-65 yearsExperimentalNot described
Receives: Device: MoCap

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. maximum displacement (in millimeters) of each marker placed on the face

    maximum displacement (in millimeters) of each marker placed on the face during standardized movements of the periorbital region

    Measured: day 1

Secondary outcomes (6)
  1. Coefficient of variation of the maximum displacement amplitudes measured during repeated tests for the same movement.

    Measured: day 1

  2. The correlation coefficient between dynamic MoCap measurements and static measurements obtained from reference tools.

    The correlation coefficient between dynamic MoCap measurements and static measurements obtained from reference tools.

    Measured: day 1

  3. The difference in the mean maximum displacement amplitudes (in millimeters) between different age groups

    The difference in the mean maximum displacement amplitudes (in millimeters) between different age groups

    Measured: day 1

  4. The difference in the mean maximum displacement amplitudes (in millimeters) before and after performing a periorbital massage

    The difference in the mean maximum displacement amplitudes (in millimeters) before and after performing a periorbital massage

    Measured: day 1

  5. The maximum mean displacement amplitudes (in millimeters) during a mechanical solicitation (a standardized vertical jump).

    The maximum mean displacement amplitudes (in millimeters) during a mechanical solicitation (a standardized vertical jump).

    Measured: day 1

  6. The difference in the mean maximum displacement amplitudes (in millimeters) before and after applying a tightening product (aloe vera).

    The difference in the mean maximum displacement amplitudes (in millimeters) before and after applying a tightening product (aloe vera).

    Measured: day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2025
  2. Study start20 Sep 2025
  3. Primary completionAug 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07080320
Sponsor's protocol ID
PI2025_843_0101
Acronym
REGARD
Status last verified
Feb 2026
First submitted
15 Jul 2025
Last updated
5 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MoCap in people with Facial Skin and Motion Capture, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 5 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

maximum displacement (in millimeters) of each marker placed on the face (time frame: day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in